Pacific Financial Statements From 2010 to 2026

Pacific Biosciences Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Common Stock Shares Outstanding 348.2 M 331.6 M 154.5 M Slightly volatile Total Assets 1.5 B 1.4 B 683.5 M Slightly volatile Short and Long Term Debt Total 812 M 773.3 M 314 M Slightly volatile Other Current Liabilities 26.5 M 29.7 M 26.8 M Slightly volatile Total Current Liabilities 52.1 M 76.2 M 53.2 M Slightly volatile Other Liabilities 2.8 M 3 M 19.7 M Pretty Stable Property Plant And Equipment Net 36.4 M 53.6 M 37.3 M Slightly volatile Current Deferred Revenue 11.3 M 15.9 M 11 M Slightly volatile Accounts Payable 20 M 19.1 M 8.9 M Slightly volatile Cash 116.3 M 63.7 M 102.3 M Slightly volatile Non Current Assets Total 923.5 M 879.5 M 335.6 M Slightly volatile Non Currrent Assets Other 13.1 M 12.5 M 6.8 M Slightly volatile Other Assets 1.09 1.15 5.2 M Very volatile Cash And Short Term Investments 291.2 M 448.4 M 286.1 M Slightly volatile Short Term Investments 404 M 384.7 M 202.8 M Slightly volatile Liabilities And Stockholders Equity 1.5 B 1.4 B 683.5 M Slightly volatile Non Current Liabilities Total 830.2 M 790.7 M 344.2 M Slightly volatile Other Current Assets 23.5 M 22.4 M 7.4 M Slightly volatile Other Stockholder Equity 3.2 B 3.1 B 1.4 B Slightly volatile Total Liabilities 910.3 M 866.9 M 399 M Slightly volatile Property Plant And Equipment Gross 155.2 M 147.8 M 59 M Slightly volatile Total Current Assets 332.1 M 570 M 332.3 M Slightly volatile Short Term Debt 7.5 M 11.5 M 7.5 M Slightly volatile Property Plant Equipment 98.2 M 93.5 M 42.3 M Slightly volatile Long Term Debt 781.8 M 744.6 M 345.1 M Slightly volatile Net Receivables 33.2 M 31.7 M 15.1 M Slightly volatile Common Stock Total Equity 189 K 198.9 K 38.1 M Slightly volatile Inventory 70.9 M 67.6 M 28.1 M Slightly volatile Common Stock 251.4 K 264.6 K 78.4 M Slightly volatile Long Term Debt Total 1.1 B 1 B 446.1 M Slightly volatile Deferred Long Term Liabilities 11.9 M 16.9 M 12.1 M Slightly volatile Non Current Liabilities Other 21 M 22.1 M 37.1 M Slightly volatile Capital Surpluse 1.2 B 2.3 B 1.2 B Slightly volatile Short and Long Term Debt 418.9 K 441 K 9.2 M Slightly volatile Net Invested Capital 711.6 M 1.3 B 465.4 M Slightly volatile Net Working Capital 468 M 493.8 M 286.8 M Slightly volatile Capital Stock 236.5 K 338.1 K 192.9 K Slightly volatile Capital Lease Obligations 34.9 M 22.4 M 43 M Slightly volatile
Pacific Biosciences Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 64.4 M 61.4 M 18.1 M Slightly volatile Total Revenue 186 M 177.1 M 97.2 M Slightly volatile Gross Profit 28.8 M 42.9 M 31.8 M Slightly volatile Other Operating Expenses 758.7 M 722.6 M 293.2 M Slightly volatile Research Development 89.8 M 155.2 M 87.6 M Slightly volatile Total Operating Expenses 617.8 M 588.3 M 228.7 M Slightly volatile Cost Of Revenue 70.2 M 134.2 M 62.8 M Slightly volatile Selling General Administrative 211.3 M 201.3 M 94.5 M Slightly volatile Interest Income 2.3 M 2.3 M 2.7 M Slightly volatile Reconciled Depreciation 64.4 M 61.4 M 18.9 M Slightly volatile Non Recurring 24.9 M 28 M 30.6 M Slightly volatile
Pacific Biosciences Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Stock Based Compensation 85.8 M 81.7 M 36.7 M Slightly volatile Begin Period Cash Flow 105.1 M 207.2 M 109.2 M Slightly volatile Depreciation 64.4 M 61.3 M 18.1 M Slightly volatile Capital Expenditures 6 M 7.1 M 5.6 M Slightly volatile End Period Cash Flow 105.8 M 64.5 M 93.3 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 3.56 3.75 11.59 Pretty Stable Days Sales Outstanding 44.26 58.71 54.8756 Pretty Stable Stock Based Compensation To Revenue 0.67 0.7 0.4193 Slightly volatile Capex To Depreciation 0.13 0.116 0.6643 Slightly volatile Inventory Turnover 2.18 1.79 2.5523 Very volatile Days Of Inventory On Hand 162 211 159 Pretty Stable Payables Turnover 6.28 6.33 7.4689 Very volatile Sales General And Administrative To Revenue 0.88 0.93 1.8999 Slightly volatile Research And Ddevelopement To Revenue 0.96 1.01 1.522 Slightly volatile Capex To Revenue 0.0439 0.0462 0.1448 Slightly volatile Cash Per Share 1.55 1.63 9.7961 Slightly volatile Days Payables Outstanding 55.43 59.66 53.1524 Slightly volatile Income Quality 0.89 0.76 0.8071 Very volatile Intangibles To Total Assets 0.39 0.51 0.433 Slightly volatile Current Ratio 9.02 8.6 7.7566 Pretty Stable Receivables Turnover 8.16 6.43 7.4019 Slightly volatile Capex Per Share 0.0246 0.0259 0.2742 Slightly volatile Revenue Per Share 0.85 0.65 0.8263 Slightly volatile Interest Debt Per Share 2.36 2.25 1.3902 Slightly volatile Debt To Assets 0.5 0.48 0.2511 Slightly volatile Graham Number 2.28 2.57 2.8018 Slightly volatile Operating Cycle 154 224 192 Pretty Stable Days Of Payables Outstanding 55.43 59.66 53.1524 Slightly volatile Long Term Debt To Capitalization 0.53 0.5 0.3317 Slightly volatile Quick Ratio 8.49 7.58 7.2073 Pretty Stable Net Income Per E B T 0.7 0.9 0.7318 Slightly volatile Cash Ratio 0.91 0.96 2.8341 Slightly volatile Cash Conversion Cycle 117 177 146 Pretty Stable Days Of Inventory Outstanding 162 211 159 Pretty Stable Days Of Sales Outstanding 44.26 58.71 54.8756 Pretty Stable Free Cash Flow Operating Cash Flow Ratio 1.17 1.18 1.0727 Very volatile Fixed Asset Turnover 2.37 2.97 3.2678 Pretty Stable Debt Ratio 0.5 0.48 0.2511 Slightly volatile Price Sales Ratio 3.56 3.75 11.59 Pretty Stable Asset Turnover 0.1 0.11 0.2896 Pretty Stable Gross Profit Margin 0.28 0.22 0.3414 Pretty Stable
Pacific Biosciences Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 3.9 B 3.7 B 3.9 B Slightly volatile

Pacific Fundamental Market Drivers

Pacific Upcoming Events

About Pacific Biosciences Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Pacific Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pacific Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pacific Biosciences Of Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pacific Biosciences Of Stock:

How To Invest In Pacific Details

Is Pacific Stock a good investment? Details

What is Pacific Biosciences' Net Worth? Details

Largest Life Sciences Tools & Services Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details